Psoriasis Clinical Trial

Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis

Summary

This is a multi-center, open-label extension (OLE) study in patients with plaque psoriasis who have completed their participation in a previous plaque psoriasis study of ESK-001.

View Full Description

Full Description

This study will consist of patients who have completed their participation in a previous plaque psoriasis study of ESK-001. Each patient will be assigned to receive ESK-001 at one of two open-label dose levels. Patients have the option to remain on study until ESK-001 is commercially available.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Must have completed a prior ESK-001 study
Men and Women must use highly effective methods of contraception for the entirety of the study

Exclusion Criteria:

Pregnancy
Received a prohibited concomitant medication

Study is for people with:

Psoriasis

Phase:

Phase 2

Estimated Enrollment:

165

Study ID:

NCT05739435

Recruitment Status:

Active, not recruiting

Sponsor:

Alumis Inc

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 38 Locations for this study

See Locations Near You

Investigator Site # 1029
Birmingham Alabama, 35205, United States
Investigator Site #1001
Phoenix Arizona, 85032, United States
Investigator Site # 1023
Rogers Arkansas, 72758, United States
Investigator Site #1021
Encinitas California, 92024, United States
Investigator Site #1018
Los Angeles California, 90045, United States
Investigator Site #1007
Santa Monica California, 90404, United States
Investigator Site #1002
Sherman Oaks California, 91403, United States
Investigator site # 1030
Fort Lauderdale Florida, 33308, United States
Investigator Site #1025
Hialeah Florida, 33012, United States
Investigator site # 1028
Miami Florida, 33175, United States
Investigator Site # 1013
Tampa Florida, 33614, United States
Investigator Site #1035
Macon Georgia, 31217, United States
Investigator Site #1043
Sandy Springs Georgia, 30328, United States
Investigator Site #1005
Rolling Meadows Illinois, 60008, United States
Investigator Site # 1011
Columbus Indiana, 47201, United States
Investigator Site #1027
South Bend Indiana, 46617, United States
Investigator SIte#1036
Overland Park Kansas, 66210, United States
Investigator Site #1017
Owensboro Kentucky, 42301, United States
Investigator Site #1026
Rockville Maryland, 20850, United States
Investigator Site #1010
Clarkston Michigan, 48346, United States
Investigator Site #1031
New Brighton Minnesota, 55112, United States
Investigator Site #1033
Norman Oklahoma, 73071, United States
Investigator Site #1019
Portland Oregon, 97223, United States
Investigator Site #1022
Philadelphia Pennsylvania, 19103, United States
Investigator Site # 1012
Rapid City South Dakota, 57702, United States
Investigator Site #1015
Houston Texas, 77056, United States
Investigator Site # 1006
San Antonio Texas, 78213, United States
Investigator Site # 1041
South Jordan Utah, 84095, United States
Investigator Site #2001
Edmonton Alberta, T6G 1, Canada
Investigator Site # 2008
Surrey British Columbia, V3V 0, Canada
Investigator Site #2003
Winnipeg Manitoba, R3M 3, Canada
Investigator Site #2006
London Ontario, N6H 5, Canada
Investigator Site # 2004
Mississauga Ontario, L4Y 4, Canada
Investigator Site # 2007
North Bay Ontario, PiB 3, Canada
Investigator Site #2005
Oakville Ontario, L6J 7, Canada
Investigator Site #2009
Toronto Ontario, M3H 5, Canada
Investigator Site # 2002
Waterloo Ontario, N2J 1, Canada
Investigator Site # 2010
Quebec , G1V 4, Canada

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 2

Estimated Enrollment:

165

Study ID:

NCT05739435

Recruitment Status:

Active, not recruiting

Sponsor:


Alumis Inc

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider